Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03028194
NCT03028194
Completed
Not Applicable

Effects of Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia: A Randomized, Controlled Trial

Saint Thomas Hospital, Panama2 sites in 1 country442 target enrollmentOctober 1, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPre-EclampsiaEclampsia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pre-Eclampsia
Sponsor
Saint Thomas Hospital, Panama
Enrollment
442
Locations
2
Primary Endpoint
Systolic and diastolic blood pressure
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Use of Postpartum uterine curettage in reducing hospitalization time or in improving the clinical evolution of the patient with preeclampsia/eclampsia.

Detailed Description

To evaluate if postpartum uterine curettage improved the clinical and laboratory parameters in patients with preeclampsia or eclampsia. A total of 442 patients with preeclampsia/eclampsia were randomized to postpartum curettage (223) or no procedure (219). Systolic and diastolic blood pressure were recorded and analyzed at hours 6, 12, 24 and 48. Also, several laboratory values and diuresis were evaluated.

Registry
clinicaltrials.gov
Start Date
October 1, 2015
End Date
December 11, 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Saint Thomas Hospital, Panama
Responsible Party
Principal Investigator
Principal Investigator

Osvaldo A. Reyes T.

Head of the Research Department

Saint Thomas Hospital, Panama

Eligibility Criteria

Inclusion Criteria

  • •Gestational age 24 weeks or more.
  • •Preeclampsia/eclampsia

Exclusion Criteria

  • •Epilepsy or seizures previous to pregnancy.
  • •Renal disease
  • •Heart disease
  • •Liver disease

Outcomes

Primary Outcomes

Systolic and diastolic blood pressure

Time Frame: 48 hours

Arterial Blood pressure

Secondary Outcomes

  • Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests).(48 hours)
  • Seizures(48 hours)

Study Sites (2)

Loading locations...

Similar Trials

Terminated
Not Applicable
Optimizing the Management of Postpartum Urinary RetentionUrinary Retention
NCT04187365Northwestern University70
Completed
Not Applicable
The impact of uterine re-curettage on the number of chemotherapy courses in treatment of post molar gestational trophoblastic neoplasia. A randomized – controlled study.Persistent trophoblastic disease, molar pregnancy, chemotherapy, curettage.Persisterende trofoblast, mola zwangerschap, chemotherapie, curettage
NL-OMON23724HC van Doorn ErasmusMC, Daniel den HoedclinicRotterdam+31107041263h.vandoorn@erasmusmc.nlNo sponsor80
Completed
Not Applicable
Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean SectionScar; Previous Cesarean SectionComplications; Cesarean Section, Wound, Dehiscence
NCT02703519Martin-Luther-Universität Halle-Wittenberg116
Recruiting
Not Applicable
Clinical Impact of Uterine Repair During Cesarean Section with Barbed Suture on the Incidence of IsthmoceleIsthmoceleCesarean Scar DefectPelvic PainSpottingInfertilityUterine NicheUterine Abnormal BleedingNiche
NCT06691750Hospital Clinic of Barcelona364
Recruiting
Not Applicable
Placenta Accreta Spectrum Outcome After Uterine ConservationPlacenta Accreta Spectrum
NCT04866888Alexandria University120